TRAVERE THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 4893000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2015-09-30) |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c5d774ab-fcbc-4a71-8dd3-5236a817755e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-15-008436Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/accounts-payable/2015-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c5d774ab-fcbc-4a71-8dd3-5236a817755e
History
- no predecessors — first report